LitSource vs Isomorphic Labs

Side-by-side comparison of features, pricing, and ratings

Analysis reviewed Live tool data as of 2026-10-09
Cross-checked through our multi-step verification ·
Saved

At a glance

DimensionLitSourceIsomorphic Labs
PricingFreemium (free tier available)Contact (enterprise partnerships only)
Best ForIndividual researchers, students, cliniciansLarge pharma companies, multi-billion-dollar pipelines
Primary FunctionCitation verification & literature evidence retrievalAI-driven drug discovery & molecular design
Data SourcePubMed, CrossRef, OpenAlex, Semantic ScholarProprietary models + partner data
Access ModelSelf-serve web app + Chrome extensionClosed platform (partnerships only)

If you're a pharma giant developing protein-targeted therapies and can commit to a multi-year, multi-million-dollar partnership, Isomorphic Labs is your only ticket. For the vast majority of biomedical researchers, clinicians, and students who need to verify AI-generated references or find evidence for a claim in minutes, LitSource delivers immediate, affordable value with a freemium tier and deep PubMed integration. These tools address fundamentally different stages of the drug development pipeline — discovery vs. evidence validation — and your choice depends entirely on your budget and scale.

LitSource
LitSource

LitSource reverse-matches your claims to real PubMed and Crossref papers and flags fake citations before you submit.

Visit Website
Isomorphic Labs
Isomorphic Labs

Isomorphic Labs applies generative AI drug discovery to design novel molecules and predict how candidates will perform.

Visit Website
Pricing
Freemium
Contact Sales
Plans
$0/mo
$12.99/mo
One-time purchase
—
Popularity
5 views
7.5k views
Skill Level
Intermediate
Advanced
API Available
Platforms
WebPlugin
—
Categories
🔬 Research & Education🎓 Academic Writing & Citations
🧬 Drug Discovery & Life Sciences
Features
AI semantic search that reverse-matches a sentence or paragraph to real papers
Citation Checker flagging references as Verified, Suspicious, or Fake
Batch DOI and metadata validation against PubMed, PMC, Crossref, OpenAlex, Semantic Scholar
Sentence-level full-text extraction with highlighting of the supporting claim
Sentence-level reference mapping that links bracketed markers like [3] to the sentence they support
Structured retraction detection using PubMed publication types and the OpenAlex is_retracted flag
Retraction badges on papers in evidence search
PubMed PMID resolution during citation verification
Biomedical entity recognition for drugs, diseases, genes, and populations
Evidence type filtering: Support, Partial, Against, Uncertain
Impact factor sorting and journal quartile filtering
Filters by publication year and article section (Intro/Methods/Results/Discussion)
Bilingual claim input auto-converted into English PubMed-style queries
Open-access PDF retrieval with source, license, and version metadata
Reference export in APA, MLA, Chicago, BibTeX, RIS, CSV, EndNote, Zotero, Mendeley
Drug Design Engine spanning generative molecule design through lead optimization
Predictive AI models that anticipate how candidate drugs will perform
Generative models for designing novel molecules
Builds on and beyond the Nobel-winning AlphaFold system
End-to-end research collaborations from target identification to lead optimization
Digital biology approach aimed at discovery at digital speed
Named pharma partners include Johnson & Johnson, Novartis and Eli Lilly
Joined the Virtual Biology Initiative to build foundational data for AI disease models
Funder of Biohub's $1.8B initiative to train AI models that predict cell behavior
Bioresilience framework for biological threats and health emergencies
Series B investment round announced May 2026 to scale the Drug Design Engine
Follows a $600M external raise in March 2025
President Max Jaderberg appointed November 2025 to integrate AI and science
Interdisciplinary team of drug discovery experts and ML specialists
Founded by Demis Hassabis, who serves as CEO
Integrations
PubMed
PMC
Crossref
OpenAlex
Semantic Scholar
EndNote
Zotero
Mendeley

Who should pick which

  • Big Pharma VP of R&D
    Pick: Isomorphic Labs

    Isomorphic Labs directly accelerates lead optimization through AI-driven protein-ligand modeling, and its partnership model (Novartis, J&J) aligns with large-scale pipeline needs. Not accessible via self-serve.

  • Postdoc writing a grant
    Pick: LitSource

    LitSource's freemium access and sentence-level evidence extraction let the postdoc quickly find supporting citations for hypotheses and verify references, reducing the risk of AI hallucinations in the draft.

  • Medical student checking AI-generated references
    Pick: LitSource

    LitSource's Citation Checker and evidence type filtering are direct solutions for detecting fake or mismatched citations, a known problem with LLM outputs. The free tier is sufficient for student needs.

  • Systematic review team
    Pick: LitSource

    LitSource provides traceable, auditable literature search with sentence-level extraction and export to reference managers, though it is not a full systematic review automation tool.

  • Small biotech startup without pharma partnership
    Pick: LitSource

    Isomorphic Labs is inaccessible without a partnership. LitSource offers self-serve evidence retrieval for literature-based target validation, and its freemium model fits limited budgets.

Frequently Asked Questions

LitSource vs Isomorphic Labs: which should you choose?

If you're a pharma giant developing protein-targeted therapies and can commit to a multi-year, multi-million-dollar partnership, Isomorphic Labs is your only ticket. For the vast majority of biomedical researchers, clinicians, and students who need to verify AI-generated references or find evidence for a claim in minutes, LitSource delivers immediate, affordable value with a freemium tier and deep PubMed integration. These tools address fundamentally different stages of the drug development pipeline — discovery vs. evidence validation — and your choice depends entirely on your budget and scale.

Can I use Isomorphic Labs as an individual researcher?

No. Isomorphic Labs only operates through large pharma partnerships (Novartis, Johnson & Johnson). It is not available as a self-serve API or software.

Is LitSource free?

Yes, LitSource has a freemium model with a free tier that includes a limited number of searches and citation checks per month. Paid plans unlock higher usage limits.

Which tool can detect fake PubMed references from ChatGPT?

LitSource. Its Citation Checker batch-validates DOIs and metadata against PubMed/CrossRef, and its semantic search finds exact supporting sentences to confirm claims.

Does Isomorphic Labs have a Chrome extension?

No. Isomorphic Labs is a closed platform with no browser extension. LitSource offers a Chrome extension called PubMed Search Assistant Lite.

What databases does LitSource search?

LitSource connects to PubMed, CrossRef, OpenAlex, Semantic Scholar, and PMC, covering over 100 million peer-reviewed papers.

How much funding has Isomorphic Labs raised?

Isomorphic Labs announced a $600M external investment round in March 2025 and a Series B in February 2026 (undisclosed amount).

Can I export citations from LitSource?

Yes, LitSource supports export in APA/MLA/Chicago/BibTeX/Vancouver, as well as RIS/BibTeX for reference managers like Zotero, EndNote, and Mendeley.

Is Isomorphic Labs based on AlphaFold?

Yes, Isomorphic Labs builds on DeepMind's Nobel Prize-winning AlphaFold system, using it as a foundation for predictive and generative AI in drug design.

More LitSource or Isomorphic Labs comparisons

Explore each tool further

Browse these categories

Still deciding? Get the weekly AI tools brief

One email a week — new tools, honest comparisons, no spam.

Last reviewed: July 2, 2026